World Pharma News Digest - 02.04.2012

2 views
Skip to first unread message

Ruslan David

unread,
Apr 2, 2012, 4:42:14 AM4/2/12
to worldph...@googlegroups.com
Want to place your News, Brand, Service, Product or Event in front of World Pharma News?
World Pharma News' strong, innovative capabilities can ensure you to create a compelling advertising campaign that reaches all your objectives and desired audiences. For further information, please download World Pharma News' Media Pack (.pdf, 319 KB).
Read more...
http://www.worldpharmanews.com/contact-us
 
DNA sequencing lays foundation for personalized cancer treatment
‎Scientists at Washington University School of Medicine in St. Louis are using powerful DNA sequencing technology not only to identify mutations at the root of a patient's tumor - considered key to personalizing cancer treatment - but to map the genetic evolution of disease and monitor response to treatment.
Read more...
http://www.worldpharmanews.com/research/2026-dna-sequencing-lays-foundation-for-personalized-cancer-treatment
 
The next frontier in battle against atherosclerosis
‎New strategies injecting cardiovascular disease (CVD) patients with vaccines and monoclonal antibodies to combat atherosclerosis could soon change the treatment landscape of heart disease.
Read more...
http://www.worldpharmanews.com/research/2025-the-next-frontier-in-battle-against-atherosclerosis
 
The 'living' micro-robot that could detect diseases in humans
‎A tiny prototype robot that functions like a living creature is being developed which one day could be safely used to pinpoint diseases within the human body. Called 'Cyberplasm', it will combine advanced microelectronics with latest research in biomimicry (technology inspired by nature).
Read more...
http://www.worldpharmanews.com/research/2024-the-living-micro-robot-that-could-detect-diseases-in-humans
 
The path to personalized cancer treatment
‎In the largest study of its kind, researchers have profiled genetic changes in cancer with drug sensitivity in order to develop a personalised approach to cancer treatments. The study is published in Nature on Thursday 29 March 2012.
Read more...
http://www.worldpharmanews.com/research/2023-the-path-to-personalized-cancer-treatment
 
Novartis launches the Cancer Cell Line Encyclopedia (CCLE) to catalogue world's cancer cell lines
‎Novartis and the Broad Institute have developed a cancer cell line encyclopedia that catalogues the genetic and molecular profiles of almost 1,000 human cancer cell lines used in drug research and development. Results of the collaboration, published in the journal Nature, may allow scientists around the world to use this information to improve cancer clinical trial design and further cancer research.
Read more...
http://www.worldpharmanews.com/novartis/2022-novartis-launches-the-cancer-cell-line-encyclopedia-ccle-to-catalogue-worlds-cancer-cell-lines
 
Bayer HealthCare and Beijing's Tsinghua University extend innovative drug discovery partnership
‎Bayer HealthCare Company Ltd and Tsinghua University in Beijing, China, are expanding their joint research partnership relating to the Bayer-Tsinghua Joint Research Center for Innovative Drug Discovery (BTC). This week, both partners signed a new strategic agreement to collaborate in the area of biomedical sciences over the next 3 years.
Read more...
http://www.worldpharmanews.com/bayer/2021-bayer-healthcare-and-beijings-tsinghua-university-extend-innovative-drug-discovery-partnership
 
Single antibody shrinks variety of human tumors transplanted into mice
‎Human tumors transplanted into laboratory mice disappeared or shrank when scientists treated the animals with a single antibody, according to a new study from the Stanford University School of Medicine.
Read more...
http://www.worldpharmanews.com/research/2020-single-antibody-shrinks-variety-of-human-tumors-transplanted-into-mice
 
Sanofi and Regeneron report phase 2 data for potential first-in-class lipid-lowering PCSK9 antibody
‎Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) presented data from two Phase 2 trials with SAR236553/REGN727, an investigational, high-affinity, subcutaneously administered, fully-human antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9)
Read more...
http://www.worldpharmanews.com/sanofi/2019-sanofi-and-regeneron-report-phase-2-data-for-potential-first-in-class-lipid-lowering-pcsk9-antibody
 
US court denies preliminary injunction application against the FDA and dismisses AstraZeneca's lawsuit
‎The US District Court for the District of Columbia issued an opinion and order in AstraZeneca's lawsuit against the US Food and Drug Administration (FDA) regarding final marketing approval of generic quetiapine. The Court denied the company's request for a preliminary injunction and dismissed the lawsuit without prejudice.
Read more...
http://www.worldpharmanews.com/astrazeneca/2018-us-court-denies-preliminary-injunction-application-against-the-fda-and-dismisses-astrazenecas-lawsuit
 
Diabetes drug can prevent heart disease
The widely used diabetes medicine metformin can have protective effects on the heart, reveals a new study conducted at the Sahlgrenska Academy, at the University of Gothenburg, Sweden.
Read more...
http://www.worldpharmanews.com/research/2017-diabetes-drug-can-prevent-heart-disease
 
PharmaNews.eu / Latest News
 
 
 
European medicines regulators agree a common, Europe-wide approach for the identification of commercially confidential information and personal data
http://www.pharmanews.eu/ema/1027-european-medicines-regulators-agree-a-common-europe-wide-approach-for-the-identification-of-commercially-confidential-information-and-personal-data
 
EU Clinical Trials Register information now available through WHO’s International Clinical Trials Registry Platform
http://www.pharmanews.eu/ema/1026-eu-clinical-trials-register-information-now-available-through-whos-international-clinical-trials-registry-platform
 
 
 
 
With best regards,
Ruslan David
Administrator/Editor
 
 
PS: Download World Pharma News' Media Pack (.pdf, 214 KB) http://www.worldpharmanews.com/images/media_pack.pdf
Reply all
Reply to author
Forward
0 new messages